Detailed answers about BIRMINGHAM CENTRE FOR CANCER AND GENOMIC MEDICINE LLP, including incorporation, status, business activity, and accounts information.
When was BIRMINGHAM CENTRE FOR CANCER AND GENOMIC MEDICINE LLP founded?
BIRMINGHAM CENTRE FOR CANCER AND GENOMIC MEDICINE LLP was officially incorporated on 9 November 2022 and is registered under company number OC444594. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is BIRMINGHAM CENTRE FOR CANCER AND GENOMIC MEDICINE LLP?
Limited Liability Partnership. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of BIRMINGHAM CENTRE FOR CANCER AND GENOMIC MEDICINE LLP?
BIRMINGHAM CENTRE FOR CANCER AND GENOMIC MEDICINE LLP's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What is BIRMINGHAM CENTRE FOR CANCER AND GENOMIC MEDICINE LLP's registered address?
The registered office address of BIRMINGHAM CENTRE FOR CANCER AND GENOMIC MEDICINE LLP is C/O MEDMIN SERVICES LTD, 3RD FLOOR, TRIGATE HOUSE, HAGLEY ROAD WEST, BIRMINGHAM, ENGLAND, B68 0NP. This is the official address filed with Companies House for legal and statutory correspondence.
Is BIRMINGHAM CENTRE FOR CANCER AND GENOMIC MEDICINE LLP financially stable?
The most recent accounts for BIRMINGHAM CENTRE FOR CANCER AND GENOMIC MEDICINE LLP were made up to 31 March 2025, filed as UNAUDITED ABRIDGED. Next accounts are due by 31 December 2026.